ASE Technology (ASX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Net revenues reached NT$168,569 million in Q3 2025, up 11.8% sequentially and 5.3% year-over-year, with both ATM and EMS businesses outperforming sales and profitability expectations.
Net income attributable to shareholders was NT$10,870 million, up 45% quarter-over-quarter and 12% year-over-year.
Basic EPS was NT$2.50, up 44% sequentially and 11% year-over-year.
AI and LEAP services, along with high utilization in advanced packaging and testing, drove growth, supported by strong customer demand and pre-booking trends.
Profitability benefited from higher factory loading but was negatively impacted by NT dollar appreciation against the US dollar.
Financial highlights
Gross profit was NT$28,877 million with a gross margin of 17.1%, improving 0.1% sequentially and 0.6% year-over-year.
Operating profit was NT$13,201 million, up NT$3 billion sequentially and NT$1.7 billion year-over-year; operating margin was 7.8%.
EBITDA for the quarter was NT$32,613 million.
Net income was NT$10,870 million, up NT$3,349 million sequentially and NT$1,137 million year-over-year; effective tax rate was 19%.
Cash and cash equivalents stood at NT$75,142 million as of September 30, 2025.
Outlook and guidance
Q4 2025 consolidated revenue expected to grow 1%-2% quarter-over-quarter; gross and operating margins to increase by 70-100 basis points.
ATM Q4 revenue projected to grow 3%-5% sequentially, with gross margin up 100-150 basis points.
EMS Q4 revenue expected to be flat or slightly down; operating margin to remain similar to Q4 2024.
Full-year ATM revenue expected to exceed target, growing over 20% year-over-year in USD terms; leading-edge revenue on track for $1.6 billion in 2025.
CapEx to increase further to support capacity and business momentum into 2026.
Latest events from ASE Technology
- Strong 2025 results and robust 2026 outlook driven by AI, advanced packaging, and margin gains.ASX
Q4 20255 Feb 2026 - Q2 2024 net income rose to NT$7.8B on higher revenues and strong leading-edge demand.ASX
Q2 20243 Feb 2026 - Q3 2024 net income rose to NT$9,666m on strong packaging, test, and capex for future growth.ASX
Q3 202417 Jan 2026 - Advanced packaging and testing drove 2024 growth, with strong 2025 outlook and major CapEx planned.ASX
Q4 20248 Jan 2026 - Q1 2025 net income up 33% year-over-year; ATM drives growth, EMS faces softness.ASX
Q1 202520 Dec 2025 - 7–9% revenue growth in H1/Q2 2025, led by advanced packaging and testing momentum.ASX
Q2 20256 Nov 2025